# Medanta, The Medicity, India

Organization · id `cardio:org-medanta-the-medicity-india` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Medanta%2C+The+Medicity%2C+India>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Medanta, The Medicity, India
- Sponsor class: OTHER

## Connected pages

- Sponsors: Pneumatic Compression for Preventing Venous Thromboembolism (`cardio:ct-nct02040103`)
- Sponsors: Asian Diabetes Outcomes Prevention Trial (`cardio:ct-nct04286399`)
- Sponsors: Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes (`cardio:ct-nct05457933`)

## Provenance

Content hash: 0b45fbb920fcd515d38338d6ee7026c607834b79c8d306ce210275e10db24553
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
